![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Alzheimer's Drug Candidate Caprospinol Shows Favorable Results in Acute Toxicity Study
August 29, 2006 10:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 29, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's research compound Caprospinol (SP-233) demonstrated...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Strengthens Business Development Capability
August 23, 2006 11:14 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 23, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it is strengthening its business development capability with...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharmaceuticals Inc. Purchases Back Canadian Rights for HIV Drug from Quest PharmaTech
August 08, 2006 10:34 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 8, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has purchased back the Canadian licensing rights related to...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Plans to Acquire Metastatin Pharmaceuticals to Buy Rights to Novel Cancer Drug
July 27, 2006 10:06 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 27, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that Samaritan has signed a letter of intent ("LOI") whereby...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Reports Its Alzheimer's Drug Caprospinol Cleans the Brain of Plaque in Preclinical Animal Study
July 11, 2006 09:51 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 11, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's drug SP-233 (Caprospinol), not only stops amyloid...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Builds Up Patent Portfolio: Samaritan Announces U.S. Patent Issued for Peripheral-Type Benzodiazepine Receptor Associated Proteins
June 26, 2006 09:37 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 26, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it is continuing to expand its broad worldwide patent portfolio in...
![Samaritan Pharmaceuticals SEO Logo](http://www.globenewswire.com/en/Attachment/LogoDisplay/216058?filename=216058.jpg&size=2)
Samaritan Receives a Notice of Claim Allowance in its European Patent for New Type of Plaque Clearing Cardiovascular Drug SP-1000
June 20, 2006 10:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 20, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it has received a notice of allowance of claims for European patent...